Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer
NCT00557492
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
59
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
Avastin (bevacizumab)
DRUG:
Gemzar (Gemcitabine)
RADIATION:
external beam radiotherapy
Sponsor
Amer Zureikat